Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.Nesuparib has antitumor activity and can be used in the treatment of tumors, endocrine and metabolic disorders, genitourinary disorders, and can be used in the study of neuropathic pain, neurodegenerative disorders, and cardiovascular diseases.
Molekulargewicht:
400.48
Reinheit:
99.94%
CAS Nummer:
[2055357-64-5]
Formel:
C23H24N6O
Target-Kategorie:
Wnt/beta-catenin|||PARP
T61932
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten